Inhibitor of cysteine proteases is critical for motility and infectivity of Plasmodium sporozoites

mBio

Volumn 4, Issue 6, 2013, Pages

  Boysen, Katja E ^a   Matuschewski, Kai ^a,b  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; FALSTATIN; UNCLASSIFIED DRUG; PROTOZOAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MALARIA; MATURATION; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; SALIVARY GLAND; SPOROZOITE; ANIMAL; ANOPHELES; C57BL MOUSE; ENZYMOLOGY; GENE DELETION; GENETICS; LOCOMOTION; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; ANOPHELES; CYSTEINE PROTEINASE INHIBITORS; GENE DELETION; LOCOMOTION; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; SALIVARY GLANDS; SPOROZOITES;

EID: 84891609297     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00874-13     Document Type: Article

References (55)

1. Palermo C, Joyce JA. 2008. Cysteine cathepsin proteases as pharmaco logical targets in cancer. Trends Pharmacol. Sci. 29:22-28
2. Turk B. 2006. Targeting proteases: successes, failures and future pros pects. Nat. Rev. Drug Discov. 5:785-799
3. Rosenthal PJ. 2004. Cysteine proteases of malaria parasites. Int. J. Para sitol. 34:1489-1499
4. Rosenthal PJ. 2011. Falcipains and other cysteine proteases of malaria parasites. Adv. Exp. Med. Biol. 712:30-48
5. Sajid M, Robertson SA, Brinen LS, McKerrow JH. 2011. Cruzain: the path from target validation to the clinic. Adv. Exp. Med. Biol. 712: 100-115
6. Teixeira C, Gomes JR, Gomes P. 2011. Falcipains, Plasmodium falci parum cysteine proteases as key drug targets against malaria. Curr. Med. Chem. 18:1555-1572
7. Sijwali PS, Rosenthal PJ. 2004. Gene disruption confirms a critical role for the cysteine protease falcipain 2 in hemoglobin hydrolysis by Plasmo dium falciparum. Proc. Natl. Acad. Sci. U. S. A. 101:4384-4389
8. Hogg T, Nagarajan K, Herzberg S, Chen L, Shen X, Jiang H, Wecke M, Blohmke C, Hilgenfeld R, Schmidt CL. 2006. Structural and functional characterization of falcipain 2, a hemoglobinase from the malarial para site Plasmodium falciparum. J. Biol. Chem. 281:25425-25437
9. Drew ME, Banerjee R, Uffman EW, Gilbertson S, Rosenthal PJ, Gold berg DE. 2008. Plasmodium food vacuole plasmepsins are activated by falcipains. J. Biol. Chem. 283:12870-12876
10. Chugh M, Sundararaman V, Kumar S, Reddy VS, Siddiqui WA, Stuart KD, Malhotra P. 2013. Protein complex directs hemoglobin to hemozoin formation in Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 110:5392-5397
11. Blackman MJ. 2008. Malarial proteases and host cell egress: an "emerg ing" cascade. Cell. Microbiol. 10:1925-1934
12. Banyal HS, Misra GC, Gupta CM, Dutta GP. 1981. Involvement of malarial proteases in the interaction between the parasite and host eryth rocyte in Plasmodium knowlesi infections. J. Parasitol. 67:623-626.
13. Hadley T, Aikawa M, Miller LH. 1983. Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors. Exp. Parasitol. 55:306-311
14. Salmon BL, Oksman A, Goldberg DE. 2001. Malaria parasite exit from the host erythrocyte: a two step process requiring extraerythrocytic pro teolysis. Proc. Natl. Acad. Sci. U. S. A. 98:271-276
15. Wickham ME, Culvenor JG, Cowman AF. 2003. Selective inhibition of a two step egress of malaria parasites from the host erythrocyte. J. Biol. Chem. 278:37658-37663
16. Aly AS, Matuschewski K. 2005. A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J. Exp. Med. 202:225-230
17. Coppi A, Pinzon O.rtiz C, Hutter C, Sinnis P. 2005. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J. Exp. Med. 201:27-33
18. Monteiro AC, Abrahamson M, Lima AP, Vannier Santos MA, Scharfstein J. 2001. Identification, characterization, and localization of chagasin, a tight binding cysteine protease inhibitor in Trypanosoma cruzi. J. Cell Sci. 114:3933-3942
19. Rigden DJ, Mosolov VV, Galperin MY. 2002. Sequence conservation in the chagasin family suggests a common trend in cystein proteinase binding by unrelated protein inhibitors. Protein Sci. 11:1971-1977
20. Sanderson SJ, Westrop GD, Scharfstein J, Mottram JC, Coombs GH. 2003. Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens. FEBS Lett. 542:12-16
21. Engel JC, Doyle PS, Hsieh I, McKerrow JH. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734
22. Alvarez VE, Niemirowicz GT, Cazzulo JJ. 2012. The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death. Biochim. Biophys. Acta 1824: 195-206
23. Wang SX, Pandey KC, Scharfstein J, Whisstock J, Huang RK, Jacobelli J, Fletterick RJ, Rosenthal PJ, Abrahamson M, Brinen LS, Rossi A, Sali A, McKerrow JH. 2007. The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family. Structure 15:535-543
24. Figueiredo da Silva AA, de Carvalho Vieira L, Krieger MA, Goldenberg S, Zanchin NI, Guimarães BG. 2007. Crystal structure of chagasin, the endogenous cysteine protease inhibitor from Trypanosoma cruzi. J. Struct. Biol. 157:416-423
25. Pandey KC, Singh N, Arastu Kapur S, Bogyo M, Rosenthal PJ. 2006. Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion. PLoS Pathog. 2:e117. doi:10.1371/ journal.ppat.0020117
26. LaCrue AN, Sivaguru M, Walter MF, Fidock DA, James AA, Beerntsen BT. 2006. A ubiquitous Plasmodium protein displays a unique surface labeling pattern in sporozoites. Mol. Biochem. Parasitol. 148:199-209
27. Rennenberg A, Lehmann C, Heitmann A, Witt T, Hansen G, Nagarajan K, Deschermeier C, Turk V, Hilgenfeld R, Heussler VT. 2010. Exoeryth rocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepato cytes. PLoS Pathog. 6:e1000825. doi:10.1371/journal.ppat.1000825
28. Pei Y, Miller JL, Lindner SE, Vaughan AM, Torii M, Kappe SH. 2013. Plasmodium yoelii inhibitor of cysteine proteases is exported to exomem brane structures and interacts with yoelipain 2 during asexual blood stage development. Cell. Microbiol. 15:1508-1526
29. Huang R, Que X, Hirata K, Brinen LS, Lee JH, Hansell E, Engel J, Sajid M, Reed S. 2009. The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin. Mol. Biochem. Para sitol. 164:86-94
30. Besteiro S, Coombs GH, Mottram JC. 2004. A potential role for ICP, a leishmanial inhibitor of cysteine peptidases, in the interaction between host and parasite. Mol. Microbiol. 54:1224-1236
31. Santos CC, Sant'Anna C, Terres A, Cunha e Silva NL, Scharfstein J, de A Lima AP. 2005. Chagasin, the endogenous cysteine protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells. J. Cell Sci. 118:901-915
32. Janse CJ, Franke Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, Matuschewski K, van Gemert GJ, Sauerwein RW, Waters AP. 2006. High efficiency transfection of Plasmodium berghei facilitates novel selec tion procedures. Mol. Biochem. Parasitol. 145:60-70
33. Vanderberg JP. 1974. Studies on the motility of Plasmodium sporozoites. J. Protozool. 21:527-537
34. Matuschewski K. 2006. Getting infectious: formation and maturation of Plasmodium sporozoites in the Anopheles vector. Cell. Microbiol. 8:1547-1556
35. Ghosh AK, Jacobs Lorena M. 2009. Plasmodium sporozoite invasion of the mosquito salivary gland. Curr. Opin. Microbiol. 12:394-400
36. Ejigiri I, Ragheb DR, Pino P, Coppi A, Bennett BL, Soldati Favre D, Sinnis P. 2012. Shedding of TRAP by a rhomboid protease from the malaria sporozoite surface is essential for gliding motility and sporozoite infectivity. PLoS Pathog. 8:e1002725. doi:10.1371/journal.ppat.1002725
37. Yoshida N, Potocnjak P, Nussenzweig V, Nussenzweig RS. 1981. Biosynthesis of Pb44, the protective antigen of sporozoites in Plasmodium berghei. J. Exp. Med. 154:1225-1236
38. Janse CJ, Kroeze H, van Wigcheren A, Mededovic S, Fonager J, FrankeFayard B, Waters AP, Khan SM. 2011. A genotype and phenotype data base of genetically modified malaria parasites. Trends Parasitol. 27:31-39
39. Dua M, Raphael P, Sijwali PS, Rosenthal PJ, Hanspal M. 2001. Recom binant falcipain 2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol. Biochem. Parasitol. 116:95-99
40. Hanspal M, Dua M, Takakuwa Y, Chishti AH, Mizuno A. 2002. Plas modium falciparum cysteine protease falcipain 2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100:1048-1054
41. Rodriguez MH, de la Hernandez Hernandez F. 2004. Insect malaria parasites interactions: the salivary gland. Insect Biochem. Mol. Biol. 34: 615-624
42. Korochkina S, Barreau C, Pradel G, Jeffery E, Li J, Natarajan R, Shabanowitz J, Hunt D, Frevert U, Vernick KD. 2006. A mosquito specific protein family includes candidate receptors for malaria sporozoite invasion of salivary glands. Cell. Microbiol. 8:163-175
43. Ghosh AK, Devenport M, Jethwaney D, Kalume DE, Pandey A, An-Derson VE, Sultan AA, Kumar N, Jacobs Lorena M. 2009. Malaria parasite invasion of the mosquito salivary gland requires interaction be tween the Plasmodium TRAP and the Anopheles saglin proteins. PLoS Pathog. 5:e1000265. doi:10.1371/journal.ppat.1000265
44. Pimenta PF, Touray M, Miller L. 1994. The journey of malaria sporozo ites in the mosquito salivary gland. J. Eukaryot. Microbiol. 41:608-624
45. Frischknecht F, Baldacci P, Martin B, Zimmer C, Thiberge S, Olivo Marin JC, Shorte SL, Ménard R. 2004. Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell. Microbiol. 6:687-694
46. Steinbuechel M, Matuschewski K. 2009. Role for the Plasmodium sporozoite specific transmembrane protein S6 in parasite motility and efficient malaria transmission. Cell. Microbiol. 11:279-288
47. Engelmann S, Silvie O, Matuschewski K. 2009. Disruption of Plasmo dium sporozoite transmission by depletion of sporozoite invasion associated protein 1. Eukaryot. Cell 8:640-648
48. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL. 2008. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8:4680-4694
49. Cohen J, Nussenzweig V, Vekemans J, Leach A, Leach A. 2010. From the circumsporozoite protein to the RTS,S candidate vaccine. Hum. Vaccin. 6:90-96
50. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmüller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, Mtoro A, Sykes A, Ahmed S, Urassa AM, Ali AM, Mwangoka G, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Tahita MC, Kaboré W, Ouédraogo S, Sandrine Y, Guiguemdé RT, Ouédraogo JB, Hamel MJ, Kariuki S, Odero C, Oneko M, Otieno K, Awino N, Omoto J, Williamson J, Muturi Kioi V, Laserson KF, Slutsker L, Otieno W, Otieno L, Nekoye O, Gondi S, Otieno A, Ogutu B, Wasuna R, Owira V, Jones D, Onyango AA, Njuguna P, Chilengi R, Akoo P, Kerubo C, Gitaka J, Maingi C, Lang T, Olotu A, Tsofa B, Bejon P, Peshu N, Marsh K, Owusu Agyei S, Asante KP, Osei Kwakye K, Boahen O, Ayamba S, Kayan K, Owusu Ofori R, Dosoo D, Asante I, Adjei G, Adjei G, Chandramohan D, Greenwood B, Lusingu J, Gesase S, Malabeja A, Abdul O, Kilavo H, Mahende C, Liheluka E, Lemnge M, Theander T, Drakeley C, Ansong D, Agbenyega T, Adjei S, Boateng HO, Rettig T, Bawa J, Sylverken J, Sambian D, Agyekum A, Owusu L, Martinson F, Hoffman I, Mvalo T, Kamthunzi P, Nkomo R, Msika A, Jumbe A, Chome N, Nyakuipa D, Chintedza J, Ballou WR, Bruls M, Cohen J, Guerra Y, Jongert E, Lapierre D, Leach A, Lievens M, Ofori Anyinam O, Vekemans J, Carter T, Leboulleux D, Loucq C, Radford A, Savarese B, Schellenberg D, Sillman M, Vansadia P, RTS,S Clinical Trials Partnership. 2011. First results of phase 3 trial of RTS,S/AS01 ma laria vaccine in African children. N. Engl. J. Med. 365:1863-1875
51. Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BGNO, Kawende AL, Kabwende AL, Adegnika AA, Mordmüller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Bihoun B, Guiraud I, Kaboré B, Sombié O, Guiguemdé RT, Ouédraogo JB, Hamel MJ, Kariuki S, Oneko M, Odero C, Otieno K, Awino N, McMorrow M, Muturi Kioi V, Laserson KF, Slutsker L, Otieno W, Otieno L, Otsyula N, Gondi S, Otieno A, Owira V, Oguk E, Odongo G, Woods JB, Ogutu B, Njuguna P, Chilengi R, Akoo P, Kerubo C, Maingi C, Lang T, Olotu A, Bejon P, Marsh K, Mwambingu G, Owusu Agyei S, Asante KP, Osei Kwakye K, Boahen O, Dosoo D, Asante I, Adjei G, Kwara E, Chandramohan D, Greenwood B, Lusingu J, Gesase S, Malabeja A, Abdul O, Mahende C, Liheluka E, Malle L, Lemnge M, Theander TG, Drakeley C, Ansong D, Agbenyega T, Adjei S, Boateng HO, Rettig T, Bawa J, Sylverken J, Sambian D, Sarfo A, Agyekum A, Martinson F, Hoffman I, Mvalo T, Kamthunzi P, Nkomo R, Tembo T, Tegha G, Tsidya M, Kilembe J, Chawinga C, Ballou WR, Cohen J, Guerra Y, Jongert E, Lapierre D, Leach A, Lievens M, Ofori Anyinam O, Olivier A, Vekemans J, Carter T, Kaslow D, Leboulleux D, Loucq C, Radford A, Savarese B, Schellenberg D, Sillman M, Vansadia P. 2012. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367:2284-2295
52. Vanderberg JP. 1975. Development of infectivity by the Plasmodium ber ghei sporozoite. J. Parasitol. 61:43-50
53. Potocnjak P, Yoshida N, Nussenzweig RS, Nussenzweig V. 1980. Mon ovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151: 1504-1513
54. Rénia L, Miltgen F, Charoenvit Y, Ponnudurai T, Verhave JP, Collins WE, Mazier D. 1988. Malaria sporozoite penetration. A new approach by double staining. J. Immunol. Methods 112:201-205
55. Sultan AA, Thathy V, Frevert U, Robson KJ, Crisanti A, Nussenzweig V, Nussenzweig RS, Ménard R. 1997. TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 90:511-522